NIOX Group (LON:NIOX) Posts Quarterly Earnings Results

NIOX Group (LON:NIOX) issued its earnings results on Wednesday. The company reported GBX 1.41 earnings per share for the quarter, Digital Look Earnings reports. NIOX Group had a net margin of 14.37% and a return on equity of 10.14%.

NIOX Group Price Performance

Shares of NIOX traded up GBX 1 during mid-day trading on Wednesday, reaching GBX 69. 792,778 shares of the company’s stock were exchanged, compared to its average volume of 803,933. The company has a quick ratio of 1.94, a current ratio of 3.81 and a debt-to-equity ratio of 1.36. NIOX Group has a 52-week low of GBX 53.84 and a 52-week high of GBX 76. The company has a market cap of £290.40 million, a price-to-earnings ratio of 42.07 and a beta of 0.92. The company has a 50-day simple moving average of GBX 65.54 and a two-hundred day simple moving average of GBX 61.58.

NIOX Group Company Profile

NIOX Group plc is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings.

Headquartered in the UK and listed on the London Stock Exchange (ticker: NIOX), the company operates internationally, serving healthcare professionals in over 50 countries.